EUVIMED · CrossrefZeitschrift
The Hematologist
ISSN 1551-8779 · American Society of Hematology
Neueste Artikel
VEXAS Syndrome: One Clone, Many Masquerades
Prevention and Risk Assessment of Adult T-Cell Leukemia/Lymphoma in the U.S.
SKIPPER Sets Sail: Gilteritinib Makes Waves in Pediatric FLT3 Internal Tandem Duplication Acute Myeloid Leukemia
Congress Reconvenes Post-Midterms to Wrap Up Work by End of Year
A Shot at Fewer Bleeds: HMB-001 in Glanzmann Thrombasthenia
A Pioneer in Monoclonal Gammopathies and a Giant of Hematology
Marty and Matt
Factor XI Inhibition: Progress Toward Anticoagulation With Less Bleeding
The Balancing Act of Anticoagulation in Women With Acute Venous Thromboembolism and Heavy Menstrual Bleeding
Vanishing Mismatches: Human Leukocyte Antigen Loss Reshapes Donor Selection and Salvage Therapy
The ENDURing Question of Maintenance Therapy in Multiple Myeloma
Hide and Seq: Using Personalized Circulating Tumor DNA Sequencing for Measurable Residual Disease Detection in Acute Myeloid Leukemia
Transcendental? The Allure of In Vivo Maneuvers to Overcome T-Cell Exhaustion and Enhance CAR T-Cell Efficacy in High-Risk Chronic Lymphocytic Leukemia
It Takes Two to Tango: Selinexor and Ruxolitinib Duo Dancing on the Stage of Myelofibrosis
MonumenTAL and MajesTEC Steps Forward in Bispecific Antibodies for Relapsed Refractory Multiple Myeloma
Closing the Fidelity Gap: Pooled CRISPR Screens Meet Primary Acute Myeloid Leukemia Samples
Small Patients, Big Questions: Contemporary Therapeutic Strategies in Infants With Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia
Headlines From Washington
ASH Connecting Our World
Shifting Gears Toward All-Oral Induction Chemotherapy for Acute Myeloid Leukemia
Further Insight Into Mantle Cell Lymphoma Genetic Heterogeneity
The Coming Wave: How Bispecific Antibodies Are Pushing Into Early Lines of Therapy and What This Means for Academic and Community Practices
When Vein-to-Vein Is Faster Than Regulatory Approval to Access: Rethinking Global CAR-T Delivery
CAR T-Cell Therapy in Autoimmune Hematologic Disorders: Current Advances and Future Directions
Small Vessels, Big Consequences: Immune-Mediated Thrombotic Thrombocytopenic Purpura
Practicing With Calibrated Urgency When the Data Do Not Cohere
Is Intravenous Iron a ‘Wellness’ Product?
Is the Clock in the CAR Ticking? Conflicting Signals on Impact of Infusion Time of Day on Outcomes With CAR-T Therapy
Point-Counterpoint Early Intervention in Smoldering Multiple Myeloma: Pursuing Curative Strategies
Congress Finalizes FY26 Budget for NIH and Other Federal Programs, Begins Work on FY27
EUVIMED